Aprea Therapeutics, Inc.

APRE

Log in to follow and get free email alerts when insiders file.

Sector

Pharmaceutical Preparations

Industry

Drugs

Website

Recent Filings - SEC Insider Transactions (Form 3,4,5)

Date
  • today
  • yesterday
  • week
Price per share
Shares

Transaction Codes

File Date
 
Date
 
Company
 
Filer
 
Security
 
Shares
 
Price
 
$ Total
 
% Change
 
10%
 
Dir.
 
Off.
 
Code
 
View
 
SEC
 
SIC
 
SIC Group
 
SIC Division
 

      Rows per page:

      100

      0-0 of 0

    Buy / Sell (dollars)

    1 Month

    0%0%

    $0.00

    avg. $0.00

    $0.00

    avg. $0.00

    Buy/Sell Ratio

    0


    Transactions

    0

    Filers

    0

    3 Month

    0%0%

    $0.00

    avg. $0.00

    $0.00

    avg. $0.00

    Buy/Sell Ratio

    0


    Transactions

    0

    Filers

    0

    12 Month

    0%100%

    $0.00

    avg. $0.00

    $103,560.54

    avg. $8,630.05

    Buy/Sell Ratio

    0


    Transactions

    18

    Filers

    17

    24 Month

    3.7%96.3%

    $144,900.00

    avg. $144,900.00

    $3.82M

    avg. $159,275.21

    Buy/Sell Ratio

    0.038


    Transactions

    48

    Filers

    37

    Filers

    CIK
    Name
    Title
    Last Transaction
    First Transaction
    Director
    Officer
    10% Own.
    Other
    1214496SCHADE CHRISTIAN SChairman & CEO2022-08-012021-03-01
    1608536Coiante Scott MSVP, Chief Financial Officer2022-08-012021-03-01
    1789032Korbel Gregory AlanVP of Business Dev't2022-08-012021-03-01
    1187572HENNEMAN JOHN B III2022-08-012021-07-01
    1697628Peters Richard2022-08-012021-07-01
    1789042Seizinger Bernd R.2022-08-012022-08-01
    1929298Pamukcu Rifat2022-08-012022-08-01
    1757601Grissinger Michael2022-08-012022-08-01
    1929300Gilad OrenPresident, CEO2022-08-012022-08-01
    1925150Duey Marc2022-08-012022-08-01
    1789039Abrahmsen Lars B.SVP, Chief Scientific Officer2022-03-142021-03-01
    1789076Attar Eyal C.SVP, Chief Medical Officer2022-03-142021-03-01
    1815851Namouni Fouad2021-07-012021-07-01
    1769668Kelly Michael Aaron2021-07-012021-07-01
    1824615Wessels Gregory S.SVP, Chief Commercial Officer2021-03-012021-03-01